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Summary
Background: Intermittent pneumatic compression (IPC) has been used to prevent deep venous
thrombosis (DVT), but the effects of IPC on the hemodynamics of popliteal and soleal veins,
especially in patients with congestive heart failure (CHF) have not been evaluated. The aim of
this study was to evaluate the effects of IPC on the ﬂow velocity of deep veins in the lower
extremities and to compare the efﬁcacy of two different types of IPC in deep venous ﬂow
enhancement in patients with CHF.
Methods: Flow velocities of popliteal and soleal veins were recorded in 19 patients with CHF
and in 19 control subjects using a high-resolution linear probe. Peak and mean ﬂow velocities
were measured (1) at rest, (2) with sequential foot and calf IPC (SFC-IPC) which consists of an
electrically driven air compressor and four air chambers, and (3) with impulse foot IPC (IF-IPC)
which consists of a pneumatic impulse generator operated at an applied pressure of 130mmHg.
Results: In the resting condition, popliteal venous ﬂow velocity in the CHF group was attenu-
ated (12.8± 4.7 cm/s vs. 21.1± 13.5 cm/s; p < 0.05). Both SFC-IPC and IF-IPC increased venous
velocity, but the increase with IF-IPC in CHF patients was lower than that in control subjects.
In the soleal veins, after applying SFC-IPC, the peak and mean velocity in CHF increased to the
same extent as in the control group. IF-IPC increased soleal venous velocity in control subjects,
but there was no increase in CHF patients.
∗ Corresponding author at: Department of Medicine and Clinical Science, Yamaguchi University Hospital 1-1-1 Minamikogushi,
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Conclusion: Two-dimensional Doppler scanning revealed a signiﬁcant increase in the mean and
peak velocities in the soleal and popliteal veins with SFC-IPC but not with IF-IPC in patients
with CHF. These results indicate that SFC-IPC could have favorable effects in preventing DVT in
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they exceeded the 95% conﬁdence level (p < 0.05). All sta-
tistical calculations were conducted using Stat-View, versionpatients with CHF.
© 2010 Japanese College of C
Introduction
Congestive heart failure (CHF) is recognized as one of the
major risk factors for deep venous thrombosis (DVT) in the
lower extremities [1—4] and subsequent venous thromboem-
bolism (VTE). The symptoms and signs of heart failure (HF),
based on low cardiac output and elevated left and right
ventricular (LV and RV) ﬁlling pressure, such as dyspnea
on exertion, palpitation and leg edema, are usually more
noticeable than VTE and commonly hinder its detection [3].
Vascular duplex scanning imaging, obtained with a high-
resolution probe, revealed that DVT was most commonly
detected in deep small veins, especially the soleal vein
[5,6]. Although a reduced LV ejection fraction (LVEF) and
stasis of venous ﬂow in patients with CHF was thought to be
the main reason for thrombogenesis in deep veins, the ﬂow
dynamics of lower extremity veins have not been fully eval-
uated. Intermittent pneumatic compression devices (IPC)
have been used as an established method to prevent DVT in
intensive care units. The effects of IPC on venous hemody-
namics have been evaluated [7,8]. Although the theoretical
concern was that IPC might increase in venous return to the
heart, a previous study demonstrated that the application
of IPC did not alter any central hemodynamic parame-
ters in CHF [9]. Impulse foot IPC (IF-IPC) and sequential
foot and calf IPC (SFC-IPC) are widely used in a clinical
setting, and some studies have investigated venous hemo-
dynamics in the popliteal and common femoral veins in
normal subjects [7—10]. However, venous ﬂow in the soleal
vein has not been evaluated, particularly in patients with
CHF. Furthermore, which type of IPC is more effective
for increasing deep venous ﬂow in CHF patients is still
unknown. The present study was designed to evaluate the
effects of IPC on the ﬂow velocity of popliteal and soleal
veins and to compare the efﬁcacy of two different types
of IPC in deep venous ﬂow enhancement in patients with
CHF.
Methods
Subjects
Venous ﬂow was measured in the popliteal and soleal veins
in 19 patients with CHF (9 male, 10 female; mean age 54.9
years) and 19 control subjects (9 male, 10 female; mean
age 51.8 years). The enrolled CHF patients were admitted
to our hospital for treatment of acute aggravation of HF.
CHF was diagnosed by clinical manifestation, and physical
and objective examinations based on LV systolic dysfunction,
diastolic dysfunction, or both. Severity of CHF according to
the New York Heart Association (NYHA) functional class was
more than III. The central venous pressure in the CHF group
was recorded with a central venous catheter. Inferior vena
cava (IVC) collapsibility was also evaluated by ultrasonogra-
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hy as a marker of venous stasis [4]. Positive collapsibility
as deﬁned as respiratory change in IVC diameter of >50%
4]. The etiology of CHF in this cohort included ischemic
eart disease, dilated cardiomyopathy, valvular disease, and
ilated-phase hypertrophic cardiomyopathy (Table 1). None
f the control subjects had any history or clinical evidence of
F, venous dysfunction, VTE, DVT or other major risk factors
or VTE.
tudy design
he ﬂow velocities of the popliteal and soleal veins were
easured using a high-resolution linear probe (13MHz)
nterfaced with an ultrasound unit (SSD-10, Aloka, Tokyo,
apan). A custom-made probe holder was used to hold
he probe without excess compression on the deep veins
hroughout the study. The Doppler angle was maintained at
ess than 55◦. Soleal venous ﬂow was measured from the
osterior side of the leg with the subject in the prone posi-
ion. The popliteal venous ﬂow was obtained approximately
cm cephalad to the small saphenous vein junction with all
ubjects in the prone position. Venous ﬂow velocities of the
opliteal and soleal veins were measured in patients with
HF and control subjects: (1) at rest; (2) with SFC-IPC (Veno
tream 601-J, Terumo, Tokyo, Japan); and (3) with IF-IPC
AV impulse, Kobayashi Medical, Osaka, Japan) (Fig. 1). The
FC-IPC consisted of an electrically driven air compressor
nd four air chambers that were inﬂated sequentially from
he sole to the knee in approximately 10 s. The inﬂation
tarted with a slow increase in pressure in each air cham-
er. This procedure was repeated every 60 s. The pneumatic
ompression pressure was adjusted to 50mmHg. The IF-IPC
onsisted of a pneumatic impulse generator and a plas-
ic inﬂatable foot pad. This system operated at an applied
ressure of 130mmHg, a deﬂation pressure of 0mmHg, an
nﬂation time of 1 s, and a frequency of 3 impulses per
inute (Fig. 1).
tatistical analysis
alues are expressed as mean± standard deviation. The
ean values were compared using the Student’s t test for
npaired variables and Fisher’s protected least signiﬁcant
ifference test. Differences were considered signiﬁcant if.0 (SAS Institute Inc., Cary, NC, USA).
The study protocol was approved by the Institutional
eview Board at Yamaguchi University Hospital. Written
nformed consent was obtained from all participants prior
o entering the study.
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Table 1 Baseline characteristics of the control subjects and patients with congestive heart failure.
Characteristic Control (n = 19) CHF (n = 19)
Age (years), mean (SD) 51.8 (16.2) 54.9 (15.1)
Male (%) 47.4 47.4
Medications
Warfarin (%) 0 26.3*
Aspirin (%) 0 36.8*
Ticlopidine (%) 0 21.1*
Diuretic (%) 0 89.4*
ACEi (%) 0 57.9*
ARB (%) 0 36.8*
 blocker 0 73.7*
Steroid (%) 0 15.8*
Echocardiography
LVDd (mm) 45.6 (3.8) 60.4 (10.6)*
LVEF (%) 65.2 (7.7) 35.0 (14.8)*
RV-RA PG (mmHg) 16.6 (2.3) 41.4 (13.1)*
IVC diameter (mm) 13.9 (3.8) 21.6 (2.4)*
IVC collapse (%) 100 15.8*
Other ﬁndings
Central venous pressure (mmHg) — 11.8 (2.0)
BNP (pg/mL) — 827.7 (611.5)
Cardiac conditions
Ischemic heart disease (%) 0 31.6*
Dilated cardiomyopathy (%) 0 26.3*
Valvular disease (%) 0 26.3*
Other heart disease (%) 0 15.8*
CHF, congestive heart failure; SD, standard deviation; ACEi, angiotensin-converting enzyme inhibitor; ARB, angiotensin II receptor
blocker; LVDd, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction; RV-RA PG, pressure gradient between
right ventricular and right atrium; IVC, inferior vena cava; BNP, brain natriuretic peptide.
* p < 0.01 vs. control subjects.
Figure 1 Intermittent pneumatic compression devices. (A) Sequential foot and calf intermittent pneumatic compression device
(Veno Stream 601-J unit, Terumo, Tokyo, Japan): the device consists of an electrically driven air compressor and four air chambers,
which are inﬂated sequentially from the sole (1) to the knee (4) in 10 s. (B) Impulse foot intermittent pneumatic compression device
(AV impulse, Kobayashi Medical, Osaka, Japan): the device consists of a pneumatic impulse generator and one plastic inﬂatable foot
pad. This system operated at applied pressure of 130mmHg, deﬂation pressure 0mmHg and inﬂation time 1 s.
SFC-IPC, sequential foot and calf intermittent pneumatic compression device; IF-IPC, impulse foot intermittent pneumatic com-
pression device.
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Figure 2 The effects of two intermittent pneumatic compression devices on popliteal and soleal venous ﬂow velocities. Popliteal
(A) and soleal (B) venous ﬂow velocities in control subjects and in patients with CHF. With SFC-IPC, the venous ﬂow velocity increased
in the quad-phase in both groups with sequential inﬂation of the air chambers from the sole to the knee. With IF-IPC, the venous
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bﬂow velocity rose rapidly and decreased within a short time.
C, control subjects; CHF, congestive heart failure; SFC-IPC, seq
IF-IPC, impulse foot intermittent pneumatic compression device
Results
The LV end-diastolic diameter, RV-atrial pressure gradi-
ent, and diameter of the IVC were greater and LVEF
was smaller in the CHF group compared with the control
group. The mean central venous pressure in the CHF group
was 11.8± 2.0mmHg. The collapsibility of the IVC in CHF
patients was markedly poorer than in control subjects (15.8%
vs. 100%, p < 0.01) (Table 1).
Effects of IPC on venous ﬂow
Representative changes of the venous ﬂow waveform in
popliteal (A) and soleal veins (B) in control subjects and
in patients with CHF after applying the IPC at expiration
are shown in Fig. 2. With SFC-IPC, the venous ﬂow velocity
increased in the quad-phase with sequential inﬂation of the
air chambers from the sole to the knee in both groups. With
IF-IPC, the venous ﬂow velocity rose rapidly and decreased
within a short time.Popliteal vein
In the resting condition, popliteal venous ﬂow velocity
in the CHF group was attenuated (12.8± 4.7 cm/s vs.
t
p
g
1
Iial foot and calf intermittent pneumatic compression device;
1.1± 13.5 cm/s; p < 0.05) (Fig. 3). Application of SFC-IPC
ncreased the peak and mean velocity of the popliteal vein
n both control subjects and in patients with CHF. Although
pplication of IF-IPC increased peak popliteal velocity com-
ared with rest in both groups (Table 2), the magnitude of
he increased venous ﬂow with IF-IPC was smaller than that
ith SFC-IPC (Table 2). Furthermore, augmentation of peak
ow velocity with SFC-IPC in CHF patients was the same as in
ontrol subjects. However, the increase in peak ﬂow veloc-
ty with IF-IPC in CHF patients was signiﬁcantly lower than
n control subjects (Fig. 3).
oleal vein
n the resting condition, there were no differences in
he peak and mean velocity in the soleal veins between
he CHF and control groups (peak: 4.3± 3.0 cm/s vs.
.5± 1.8 cm/s; mean: 2.4± 1.9 cm/s vs. 2.0± 0.9 cm/s;
oth p = not signiﬁcant [NS]). After applying SFC-IPC,
he peak and mean velocity of the soleal vein in CHF
atients increased to the same level as in the control
roup (peak: 77.9± 30.4 cm/s vs. 71.1± 19.9 cm/s; mean:
8.0± 7.7 cm/s vs. 19.8± 8.6 cm/s; both p =NS) (Fig. 4).
F-IPC increased the peak soleal venous velocities com-
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Figure 3 The peak velocities of the popliteal vein with or
without intermittent pneumatic compression. Peak popliteal
venous ﬂow was attenuated in patients with CHF at rest. The
SFC-IPC increased peak ﬂow velocity of the popliteal vein
in patients with CHF as well as in control subjects, but the
increased velocity with IF-IPC in CHF patients was lower than
that in control subjects.
CHF, congestive heart failure; SFC-IPC, sequential foot and calf
intermittent pneumatic compression device; IF-IPC, impulse
f
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Figure 4 The peak velocities of the soleal vein with or without
intermittent pneumatic compression. There was no difference
between peak soleal venous velocities in control subjects and
in patients with CHF in the absence or presence of IPC devices.
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vein was attenuated in CHF patients; (2) after application of
SFC-IPC and IF-IPC, peak popliteal venous ﬂow velocities in
control subjects and in CHF patients increased comparedoot intermittent pneumatic compression device.
ared to rest in control subjects, but not in CHF patients.
he augmented peak ﬂow velocity after applying IF-IPC
as lower than that after applying SFC-IPC in both groups
Table 3).
w
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Table 2 Changes in popliteal venous ﬂow velocity after applying
Rest
C Peak velocity (cm/s) 21.1 ± 1
Mean velocity (cm/s) 12.7 ± 8
CHF Peak velocity (cm/s) 12.8 ± 4
Mean velocity (cm/s) 6.6 ± 2
C, control subjects; CHF, congestive heart failure; SFC-IPC, sequential
impulse foot intermittent pneumatic compression device.
* p < 0.01 vs. rest.
** p < 0.05 vs. rest.
† p < 0.01 vs. IF-IPC.
Table 3 Changes in soleal venous ﬂow velocity after applying int
Rest
C Peak velocity (cm/s) 3.5 ±
Mean velocity (cm/s) 2.0 ±
CHF Peak velocity (cm/s) 4.3 ±
Mean velocity (cm/s) 2.4 ±
C, control subjects; CHF, congestive heart failure; SFC-IPC, sequential
impulse foot intermittent pneumatic compression device.
* p < 0.01 vs. rest.
** p < 0.05 vs. rest.
† p < 0.01 vs. IF-IPC.HF, congestive heart failure; SFC-IPC, sequential foot and calf
ntermittent pneumatic compression device; IF-IPC, impulse
oot intermittent pneumatic compression device.
iscussion
he present study illustrated the effect of different types of
ntermittent pneumatic compression devices on deep venous
ow velocity in CHF patients. The most notable ﬁndings
ere as follows: (1) the peak ﬂow velocity of the poplitealith those at rest; however, for IF-IPC, the increase in
elocity in CHF patients was less than in control subjects;
intermittent pneumatic compression devices.
SFC-IPC IF-IPC
3.5 110 ± 41.5*,† 62.6 ± 44.7*
.4 41.5 ± 25.6*,† 21.7 ± 10.9
.7 85.6 ± 31.8*,† 28.6 ± 9.3**
.6 27.6 ± 10.6*,† 8.6 ± 3.9
foot and calf intermittent pneumatic compression device; IF-IPC,
ermittent pneumatic compression devices.
SFC-IPC IF-IPC
1.8 71.1 ± 19.9*,† 13.4 ± 8.7**
0.9 19.8 ± 8.6*,† 3.3 ± 1.3
3.0 77.9 ± 30.4*,† 11.3 ± 5.9
1.9 18.0 ± 7.7*,† 3.9 ± 2.0
foot and calf intermittent pneumatic compression device; IF-IPC,
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(3) although SFC-IPC increased soleal venous ﬂow in both
groups, IF-IPC failed to signiﬁcantly increase soleal venous
ﬂow in CHF.
DVT in CHF
It was reported that the occurrence of DVT in the lower
extremities was related to the severity of CHF [1—3,11],
and that the risk of VTE increased as LVEF decreased:
the odds ratio for VTE increased from 2.8 to 38.3 with a
decrease in LVEF from 45 to 20% [1], and the risk of DVT and
VTE increased according to NYHA functional class [4,12].
Furthermore, another study demonstrated that abnormal
platelet function (levels of soluble P-selectin and von Wille-
brand factor) as well as high plasma viscosity contributed to
a hypercoagulable state in CHF patients with more severe
NYHA class [13].
Deep venous ﬂow velocities in patients with CHF
Many investigators have attempted to detect DVT bymeasur-
ing the peak venous velocity in the superﬁcial femoral vein
using venous duplex ultrasound [7,14]. Recently, advances
in a high-resolution linear probe have revealed that DVT
was most commonly detected in deep veins, particularly
the soleal vein [5,6]. Thus, we focused on the venous ﬂow
velocities in soleal as well as popliteal veins.
This study revealed that popliteal venous ﬂow velocity
was lower in CHF patients than in control subjects. Venous
ﬂow velocity in lower extremity is affected by cardiac out-
put, right atrial pressure, respiration, and calf contraction
exercise [1,15,16]. The attenuation of popliteal venous ﬂow
velocity in CHF patients may be affected by increase in right
atrial pressure. On the other hand, the soleal venous ﬂow
velocity even in control subjects was as low as the veloc-
ity in CHF patients in the resting condition (Table 3; Fig. 4).
The soleal veins are peripheral veins and course beneath
soleus muscle. Because soleal veins are small in diameter,
these veins may be compressed by the muscle in lower limbs
and the venous ﬂow velocities may be low even in healthy
subjects. In CHF patients, the reduction in cardiac output
and elevated right atrial pressure may facilitate peripheral
circulatory insufﬁciency in the lower extremities and may
increase the risk of DVT. In contrast, because an increase in
venous ﬂow velocity with ankle and leg exercise in healthy
subjects is expected [15,16], the incidence of DVT may be
low in these subjects.
Effects of IPC on deep venous ﬂow
IPC is recognized as a prophylactic device against DVT
[7—10,17,18], and the guidelines for the prevention of VTE
in 2008 recommended IPC as one of the most useful devices
for prevention of VTE [19]. In this study, both SFC-IPC and
IF-IPC augmented peak velocity in popliteal veins in con-
trol and CHF subjects. SFC-IPC also augmented the soleal
venous velocity in both groups. On the other hand, IF-IPC
slightly increased soleal venous velocity in control subjects
but not in CHF patients. This different response to the two
devices on soleal venous velocity may be accounted for by389
he anatomy of the plantar venous plexus and deep veins:
he plantar venous plexus diverges into an outﬂow of one to
our veins that ﬂow into the posterior tibial venous system
nd into the popliteal vein [20]. The soleal vein also ﬂows
nto the popliteal vein via the peroneal vein and not from
he plantar venous plexus. A previous study reported that
F-IPC increased peak velocity in the posterior tibial veins
ut not in the anterior tibial and peroneal veins [20]. This
eport supported that IF-IPC might not increase venous ﬂow
n the soleal vein, which is not contiguous with the plantar
enous plexus. The SFC-IPC compresses the lower extremity
rom the sole to the knee, increasing the velocity step-by-
tep with inﬂation of each air chamber. This device also may
ncrease venous ﬂow in the deep veins and provide sufﬁcient
mprovements in venous clearance to help prevent venous
emostasis and thrombogenesis in CHF patients.
tudy limitations
n this study, we did not evaluate changes in venous diam-
ter while applying the IPC. Thus, we could not ascertain
hanges in the amount of venous ﬂow before and during
he application of IPC. Nevertheless, the radial shape of the
ein is affected by venous pressure, the amount of venous
eturn, and venous compression from surrounding tissues;
herefore, evaluation of the venous diameter throughout
he study may be unreliable. Our results suggested a pro-
hylactic mechanism of IPC in thrombogenesis. However, we
id not observe whether DVT was prevented by IPC in CHF
atients. Further follow-up study is needed to conﬁrm the
rophylactic effects of these devices in CHF patients.
onclusions
wo-dimensional Doppler scanning with a high-resolution lin-
ar probe revealed a signiﬁcant increase in mean and peak
elocities in the soleal and popliteal veins on application of
FC-IPC but not of IF-IPC in patients with CHF. These results
ndicate that SFC-IPC is likely to have a favorable effect in
reventing DVT in patients with CHF.
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